NCT00421096 2026-03-13
GEMCOL
Centre Oscar Lambret
Phase 2 Terminated
Clinical Trials
85 trialsNCT05521997 2026-03-13
Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
Washington University School of Medicine
Phase 2 Not yet recruiting
NCT07276360 2025-12-11
HypoRTCx-UG
Uganda Cancer Institute
Phase 2 Not yet recruiting
NCT07232654 2025-12-01
Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT00957411 2025-11-24
CETUXICOL
Institut Curie
Phase 2 Completed
NCT07244965 2025-11-24
Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer
Women's Hospital School Of Medicine Zhejiang University
Phase 2 Not yet recruiting
NCT07088731 2025-09-22
Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT04016389 2025-08-12
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
University Health Network, Toronto
Phase NA Recruiting
NCT03086681 2025-07-29
ECWHCCFLACC
First Affiliated Hospital of Guangxi Medical University
Phase 2 Completed
NCT06942416 2025-04-24
Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer
Shandong Cancer Hospital and Institute
Phase 2 Recruiting
NCT05857631 2025-04-15
PARCERII
Tata Memorial Centre
Phase NA Recruiting
NCT03527264 2025-04-04
BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer
Brown University
Phase 2 Terminated
NCT06558682 2025-04-01
Neoadjuvant Therapy in Cervical Cancer
Qilu Hospital of Shandong University
Phase NA Recruiting
NCT06288360 2025-03-20
Neoadjuvant Immunochemotherapy in PD-L1-negative LACC
Tongji Hospital
Phase 2 Recruiting
NCT04275713 2025-01-20
METOXY-LACC
Oslo University Hospital
Phase 2 Completed
NCT06752135 2024-12-30
HRCC1
Azienda Policlinico Umberto I
Terminated
NCT01566240 2024-12-05
INTERLACE
University College, London
Phase 3 Active not recruiting
NCT01554397 2024-11-29
Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer
University of California, San Diego
Phase 2/3 Completed
NCT06289062 2024-11-05
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
Tongji Hospital
Phase 2 Recruiting
NCT04723875 2024-11-01
Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline
Huazhong University of Science and Technology
Phase 3 Active not recruiting
NCT06288373 2024-10-30
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
Tongji Hospital
Phase 2/3 Recruiting
NCT06289751 2024-09-19
Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
Tongji Hospital
Phase 2 Recruiting
NCT05764044 2024-07-30
AddChemo
Hospital do Coracao
Phase 3 Recruiting
NCT03367871 2024-06-18
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
University of Miami
Phase 2 Terminated
NCT06419673 2024-05-17
Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Active not recruiting
NCT01088347 2024-04-19
Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer
University Medical Center Groningen
Phase 1/2 Completed
NCT06333821 2024-03-27
A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma
Biotech Pharmaceutical Co., Ltd.
Phase 3 Not yet recruiting
NCT05189028 2024-02-06
Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer
Shantou University Medical College
Phase 3 Unknown
NCT05588219 2023-11-24
Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
First Affiliated Hospital of Guangxi Medical University
Phase 2 Unknown
NCT03534713 2023-09-21
ONCOCOL01
University Hospital, Toulouse
Phase 3 Recruiting
NCT05879796 2023-05-30
Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer
Peking University Third Hospital
Not yet recruiting
NCT01755897 2023-05-09
CC-01
Huazhong University of Science and Technology
Phase NA Completed
NCT05799469 2023-04-05
Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer
Chongqing University Cancer Hospital
Phase 2 Not yet recruiting
NCT03604653 2022-08-03
Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers
Holy Name Medical Center, Inc.
Completed
NCT04772001 2022-05-18
Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer
Zhongnan Hospital
Phase NA Unknown
NCT01554410 2022-02-17
Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma
University of California, San Diego
Phase 1 Completed
NCT05105672 2021-12-28
A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer
The Affiliated Hospital of Xuzhou Medical University
Phase 2 Unknown
NCT05151549 2021-12-09
A Study of Carilizumab Combined With Concurrent Chemoradiotherapy
Hunan Cancer Hospital
Phase 2 Unknown
NCT04974944 2021-10-01
First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT04974827 2021-08-10
A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer
Hunan Cancer Hospital
Phase 2 Unknown
NCT04973904 2021-07-22
Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT01016561 2021-05-05
Magnetic Resonance Imaging-Based Radiation Therapy and Cisplatin in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Terminated
NCT02394652 2021-04-21
The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial
University Health Network, Toronto
Phase 2 Completed
NCT02624531 2021-01-07
SYSUGO-005
Sun Yat-sen University
Phase NA Unknown
NCT04017377 2020-04-28
VMAT Concurrent Cisplatin Plus Nab-paclitaxel for Local Advanced Cervical Cancer
Peking University Third Hospital
Phase NA Unknown
NCT02363829 2020-04-06
A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT01019278 2020-04-03
Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph Nodes
Abramson Cancer Center at Penn Medicine
Phase 2 Withdrawn
NCT04121975 2019-10-10
CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT01230996 2019-04-24
DEPICT
Barts & The London NHS Trust
Phase 1/2 Completed
NCT01561586 2019-02-27
TACO
Korea Cancer Center Hospital
Phase 3 Unknown